Advanced search
Combine gene, variant, phenotype, region and year filters
Every result shows the extracted entities next to the sentences that support them; rows for the searched entities come first.
Transparent by designEvery result links extracted entities to its source sentence and publication identifier.
Knowledge-base search
About your search
CD44 and multiple myeloma are reported together in 1 article.
Gene
CD44
- HGNC
- HGNC:1681
74articles
74mentions
2variants with confirmed gene link
Most co-reported phenotypes (articles)
breast cancer 14colorectal cancer 7lung cancer 4diabetes mellitus 3ovarian cancer 3epilepsy 2hepatocellular carcinoma 2inflammatory bowel disease 2
Reported variants (articles · ClinVar status)
Phenotype
Multiple myeloma
63articles
63mentions
12co-reported genes shown
Most co-reported genes (articles)
Counts are literature co-mentions in SaudiVarKB, not clinical or causal assertions. Gene details: HGNC; variant status: ClinVar via dbSNP.
Publications
1 records shown · first 60Mass spectrometry-based proteomics and metabolomics in multiple myeloma: a systematic review of prognostic biomarkers and minimal residual disease monitoring.
PMID 42100277 | PMCID PMC13143611 | DOI 10.3389/fmed.2026.1791030 · Frontiers in medicine · 2026 · 3 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | CD44 | “Eleven discovery-focused studies identified specific MS-derived signatures, such as microenvironmental proteins (e.g., MTA2, CD44) and dysregulated lipid metabolites (e.g., acylcarnitines, LysoPE) that were consistently associated with PFS and OS.” | 0.98 | hgnc_dict_v1 |
| phenotype | multiple myeloma | “Mass spectrometry-based proteomics and metabolomics in multiple myeloma: a systematic review of prognostic biomarkers and minimal residual disease monitoring.” | 0.98 | phenotype_alias_lexicon_v2 |
| gene | MTA2 | “Eleven discovery-focused studies identified specific MS-derived signatures, such as microenvironmental proteins (e.g., MTA2, CD44) and dysregulated lipid metabolites (e.g., acylcarnitines, LysoPE) that were consistently associated with PFS and OS.” | 0.98 | hgnc_dict_v1 |